HDAC9 and metabolic disease: Prior evidence has demonstrated the involvement of histone deacetylase (HDAC) in the progression of various metabolic disorders, suggesting that HDAC inhibitors (HDACi) might be an emerging treatment agent for reno-metabolic associated disorders [17].